RecruitingNCT06327516
Lysophosphatidylglycerol in Asthma Pathogenesis
Sponsor
Peking University Third Hospital
Enrollment
250 participants
Start Date
Jan 1, 2015
Study Type
OBSERVATIONAL
Conditions
Summary
The study aims to investigate the relationship between the small molecule metabolite lysophosphatidylglycerol and asthma clinical features and explore its involvement in asthma pathogenesis.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria1
- \. clinical diagnosis of asthma.
Exclusion Criteria4
- Combined with chronic obstructive pulmonary disease, bronchiectasis, pneumonia, obstructive sleep apnea hypopnea syndrome, malignant tumor
- Combined with acute and chronic respiratory failure
- Combined with severe cardiovascular disease
- Pregnant woman.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06327516
Related Trials
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
NCT06664619138 locations
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
NCT06052267393 locations
Genetic Association With Various Severities, Phenotypes and Endotypes of Asthma.
NCT061960342 locations
To Assess the Management of Patients on Global Initiative of Asthma (GINA) Step 4 and 5 Treatment in Hong Kong
NCT046397911 location
Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma
NCT047069881 location